Picture [iito] Life Science Business Portals Media Data 2022 650x100px
Organisation › Details

Forbion Growth Opportunities Fund I (Forbion Growth I)

Forbion is a dedicated life sciences venture capital firm with offices in The Netherlands, Germany and Singapore. Forbion invests in life sciences companies that are active in the (bio-) pharmaceutical space. Forbion manages well over EUR 2 billion across multiple fund strategies that cover all stages of (bio-) pharmaceutical drug development. Forbion’s current team consists of over 30 life sciences investment professionals that have built an impressive performance track record since the late nineties with investments in 87 companies. Besides financial objectives, Forbion selects investments that will positively affect the health and well-being of patients. The firm is a signatory to the United Nations Principles for Responsible Investment. Forbion operates a joint venture with BGV, the manager of seed and early-stage funds, especially focused on Benelux and Germany. *


Period Start 2020-07-09 closing, first
  Group Forbion (Group)
  Successor Forbion Growth Opportunities Fund II (Forbion Growth II)
Products Industry Forbion Growth Opportunities Fund I (Forbion Growth I)
  Industry 2 LIFE SCIENCES
Persons Person Slootweg, Sander (Forbion Capital Partners 20111 Managing Partner before ABN AMRO Capital)
  Person 2 Kersten, Dirk (Forbion 201810– General Partner before Inkef Capital + Gilde Healthcare)
Region Region Naarden
  Country Netherlands
  City n. a. Naarden
    Address record changed: 2021-04-24
Basic data Employees n. a.
  Currency EUR
  Annual sales 360,000,000 (fund size at final closing (2021) 2021-04-20)
    * Document for �About Section�: Forbion Capital Partners. (6/9/22). "Press Release: Forbion Announces First Close of Forbion Growth Opportunities Fund II at €470 Million". Naarden & Munich.
Record changed: 2022-06-12


Picture [iito] Männer Ballett 650x100px

More documents for Forbion (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Picture ConsulTech GmbH Berlin Grant Application and Coordination 650x80px

» top